Inflammatory bowel diseases and gut microbiota

Y Haneishi, Y Furuya, M Hasegawa, A Picarelli… - International journal of …, 2023 - mdpi.com
Inflammatory bowel disease (IBD) is an inflammatory disease of the gastrointestinal tract, the
incidence of which has rapidly increased worldwide, especially in develo** and Western …

Glucocorticoid therapy in inflammatory bowel disease: mechanisms and clinical practice

S Bruscoli, M Febo, C Riccardi, G Migliorati - Frontiers in immunology, 2021 - frontiersin.org
Inflammatory bowel disease (IBD) comprises ulcerative colitis (UC) and Crohn's disease
(CD). IBD etiopathology is multifactorial and involves alteration of immune cells and chronic …

IBD disease-modifying therapies: insights from emerging therapeutics

NG Kotla, Y Rochev - Trends in Molecular Medicine, 2023 - cell.com
Inflammatory bowel disease (IBD) pathogenesis is associated with gut mucosal
inflammation, epithelial damage, and dysbiosis leading to a dysregulated gut mucosal …

Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery

M Li, N Liu, J Zhu, Y Wu, L Niu, Y Liu, L Chen, B Bai… - Biomaterials, 2024 - Elsevier
Inflammatory bowel disease (IBD) is a kind of auto-immune disease characterized by
disrupted intestinal barrier and mucosal epithelium, imbalanced gut microbiome and …

A polysaccharide from Rosa roxburghii Tratt fruit attenuates high-fat diet-induced intestinal barrier dysfunction and inflammation in mice by modulating the gut …

L Wang, P Zhang, C Li, F Xu, J Chen - Food & function, 2022 - pubs.rsc.org
Obesity-induced colonic inflammation-stimulated colitis is one of the main causes of
colorectal cancer. Dietary polysaccharides are considered an effective agent for relieving …

Treatment effects of natural products on inflammatory bowel disease in vivo and their mechanisms: Based on animal experiments

Y Zhou, D Wang, W Yan - Nutrients, 2023 - mdpi.com
Inflammatory bowel disease (IBD) is a chronic, non-specific inflammatory disease of the
intestine that can be classified as ulcerative colitis (UC) and Crohn's disease (CD) …

[HTML][HTML] Cross-scale multi-instance learning for pathological image diagnosis

R Deng, C Cui, LW Remedios, S Bao, RM Womick… - Medical image …, 2024 - Elsevier
Analyzing high resolution whole slide images (WSIs) with regard to information across
multiple scales poses a significant challenge in digital pathology. Multi-instance learning …

[HTML][HTML] Mesenchymal stromal cell secretome for the treatment of immune-mediated inflammatory diseases: latest trends in isolation, content optimization and delivery …

E Munoz-Perez, A Gonzalez-Pujana, M Igartua… - Pharmaceutics, 2021 - mdpi.com
Considering the high prevalence and the complex pharmacological management of immune-
mediated inflammatory diseases (IMIDs), the search for new therapeutic approaches for their …

[HTML][HTML] The gut–immune–brain axis: an important route for neuropsychiatric morbidity in inflammatory bowel disease

RK Masanetz, J Winkler, B Winner, C Günther… - International journal of …, 2022 - mdpi.com
Inflammatory bowel disease (IBD) comprises Crohn's disease (CD) and ulcerative colitis
(UC) and is associated with neuropsychiatric symptoms like anxiety and depression. Both …

[HTML][HTML] Advances in anti-inflammatory medicinal plants and phytochemicals in the management of arthritis: A comprehensive review

Y Gandhi, R Kumar, J Grewal, H Rawat… - Food chemistry …, 2022 - Elsevier
Rheumatoid arthritis (RA) is considered to be an inflammatory disorder whereas OA is not
an overtly inflammatory disorder as RA but certain inflammatory cytokines and periodic …